PME recently announced that it has applied for FDA approval of its AI Breast Density algorithm-see:
https://hotcopper.com.au/threads/ann-rsna-update.5136604/?post_id=41983348"Working with the breast imaging team at Yale, which is one of the most highly regarded in the
US, we were able, using Visage Research Server, to anonymise over 30,000 cases. This data
was then fed into our machine learning model which was used to produce the Breast Density
algorithm. As an extra validation, we had a team of five breast imaging specialists at Yale each
curate over 500 cases using our curation tools and then tested the algorithm against these curated
cases. The results were so promising we decided to commercialise the product and have applied
for FDA approval. By using our own platform, we were able to get a project from research through
to submission for FDA approval in under 8 months which is way under what it would otherwise
have taken using traditional tools. Hence the reason we call the platform AI Accelerator."
what are peoples thoughts on this? Also there has been some market speculation that PME may make a move on VHT- does that make sense? Thoughts please.
